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Background: Three headache disorders – migraine, tension-type headache (TTH) and medication-overuse headache
(MOH) – are major contributors to population ill-health. Policy-makers need local knowledge of these to guide
priority-setting. Earlier we reported the prevalence of these disorders in Zambia; here we describe the burdens
attributable to them.
Methods: This was a cross-sectional population-based survey of adults aged 18-65 years, selected by cluster-randomized
sampling in the mostly urban Lusaka Province and mostly rural Southern Province. Interviewers visiting households
used a structured questionnaire. Diagnoses made algorithmically applied ICHD-II criteria. Burden enquiry focused on
the previous 3 months and the day before interview. Disability was estimated by applying disability weights (DWs) from
the Global Burden of Disease Survey 2010.
Results: From 1,134 households, 1,085 unrelated adults (450 male, 635 female) were interviewed (refusal rate 4.3%).
The gender- and habitation-adjusted 1-year prevalence of migraine was 22.9%, of TTH 22.8%, of headache on ≥15
days/month 11.5%, of probable MOH (pMOH) 7.1%. Reported mean intensity of migraine attacks was 2.7, representing
severe pain. People with migraine spent 10.0% of their time in the ictal state (DW: 0.433); they were therefore 4.3%
disabled overall. Disability from TTH was much lower. People with pMOH (time with headache: 37.5%; DW: 0.220) were
8.3% disabled overall. Average lost productive time in the preceding 3 months for migraine was 4.1 days from work
(6.3% loss) and 4.2 days (4.7% loss) from household work. Losses for pMOH were 4.8 days (7.4% loss) from work and
4.5 days (5.0% loss) from household work. In the population aged 18-65 years (effectively the working population),
estimated disability from migraine was 0.98%, with 1.4% of workdays lost, and from pMOH was 0.59%, with 0.53% of
workdays lost. Headache yesterday was reported by 28.3% of participants, whose average productivity yesterday was
55.9% of expectation.
Conclusions: Zambia loses 1.93% of GDP to headache, and action is required to mitigate this loss and the associated
suffering. Structured headache services with their basis in primary care are the most efficient, effective, affordable and
equitable solution. They could be implemented within the existing health-care infrastructure of Zambia. These matters
require urgent political attention.
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Three headache disorders – migraine, tension-type
headache (TTH) and medication-overuse headache
(MOH) – are major contributors to population ill-
health. Worldwide, migraine is the seventh leading
specific cause of years of life lost to disability (YLDs),
responsible for 2.9% of all YLDs, and more than half of
all YLDs attributable to neurological disorders [1-3].
This represents a substantial burden of disease. TTH is
more prevalent than migraine [2], but less disabling at
an individual level. In the Global Burden of Disease
Survey 2010 (GBD2010), it did not make a substantial
additional contribution to YLDs attributable to headache
[1,2]. Both migraine and TTH are primary headache disor-
ders, but both can lead, through mistreatment, to MOH.
This secondary disorder by definition occurs on ≥15 days/
month, and is a major contributor to disability burden at
individual level [4]. Almost certainly it is at population
level also [5,6].
For health policy-makers, all of this is important know-
ledge. Not only do headache disorders affect very large
numbers of people through their high prevalence [1,2],
imposing symptom burdens of pain, suffering and im-
paired quality of life, but through this disability burden
they cause productivity losses that carry a very substantial
financial penalty [4]. Although health-care solutions may
be challenging to implement for such large numbers of
people, it is neither humane nor economically sensible to
ignore the public-health imperative of providing care for
people with headache [7]. Effective treatments do exist [8]
and, appropriately used, are likely to be cost-saving in
most economies [7].
At national levels, policy-makers need local knowledge
to guide decision-making and priority-setting. For head-
ache disorders, this has been unavailable in many coun-
tries of the world [9]. Following its launch in 2003, the
Global Campaign against Headache [10] set out to fill
the major knowledge gaps as its first objective [11,12],
developing standard methodology and survey instru-
ments for population-based studies [13,14]. In sub-
Saharan Africa (SSA), there had been few studies of
prevalence or burden of primary headache disorders,
and most of these had been in select sub-populations
rather than population-based, with widely varying preva-
lence findings [15-23] but all consistent in one respect:
they were considerably lower than global averages [9].
We undertook a population-based study in Zambia, as a
project within the Global Campaign against Headache
[10], expressly to inform health policy-makers [24]. It
was the first such study in the African Region. It re-
vealed that the prevalences of headache generally and of
migraine specifically were in line with those observed in
Global Campaign studies conducted with similar method-
ology elsewhere: in other words, headache is as commonin SSA as in higher-income countries. Furthermore, we
noted a particular problem in urban Zambia of headache
on ≥15 days/month, much of it probable MOH (pMOH),
which was far more prevalent there than in any other
country studied [24].
Here we report the burdens attributable to these preva-
lent disorders. We focus on symptom burden, disability
and lost productive time. In addition, a population-based
study in Georgia, another lower-middle income country
[25], established that people there with headache were
willing to pay for treatment at a level that might signifi-
cantly complement public services [26]. Knowledge of
willingness-to-pay (WTP) for health care in the context of
ability to pay in resource-limited African settings might
help direct health-policy, priority-setting and decision-
making; therefore we also enquired into WTP.
Methods
Ethics
This study was approved by the University of Zambia’s
Research Ethics Committee. Verbal informed consent
was obtained from key informants and all participants
before we asked the survey questions.
Study design and procedures
The design has been described in full previously [24]
and is summarised here. The study was a cross-sectional
population-based survey of adults aged 18-65 years, se-
lected by cluster-randomized sampling in the mostly
urban Lusaka Province and the mostly rural Southern
Province. In each Province, interviewers randomly se-
lected blocks or circumscribed collections of dwellings
(clusters), one or more dwellings within each of these,
and one adult participant within each household’s
family.
In Lusaka Province, interviewers were interested fac-
ulty and advanced students from the Chainama College
of Health Sciences. In the Southern Province, interviews
were conducted by the Chikankata Epilepsy Care team,
whose staff had been conducting community and hospital-
based health-related research for over a decade. All received
training for this study.
Interviewers used a local culturally-adapted version of
the structured questionnaire developed for these surveys
by Lifting The Burden (LTB) [27], and used previously in
Russia [28], China [29] and India [30] and subsequently
in a total of 19 countries in 18 languages [14]. This was
translated according to LTB’s translation protocol [31]
from English into three local languages: Bemba and
Nyanja for Lusaka Province, and Tonga for the Southern
Province.
Enquiry was into lifetime, 1-year and 1-day prevalence
of headache and 1-year prevalence migraine, TTH, head-
ache on ≥15 days/month and pMOH. Participants who
Table 1 Symptom and disability burdens arising from
migraine at individual and population levels
Burden variable Value
Mean intensity of attack (on scale 0-3) 2.7
Mean attack frequency (per month) 3.4
Mean duration of attack (hr) 36.4
Mean time in ictal state (% of total time) 10.0
Disability weight (from GBD2010) 0.433
Mean disability per person with migraine (%) 4.3
Prevalence (adults aged 18-65 yr) (%) 22.9
Disability in entire 18-65 yr-old population (%) 0.98
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focus only on the one most bothersome to them, so
diagnoses were mutually exclusive. Interviewers did not
make diagnoses. These were derived during analysis,
algorithmically [14], from the recorded survey responses.
Participants reporting headache on ≥15 days/month were
first separated from this process, and described as a separ-
ate group because they cannot be adequately diagnosed
by questionnaire [14]. However, those also reporting use
of headache medication regularly on >3 days/week were
considered to have pMOH. To all others, the algorithm
applied ICHD-II criteria in the order: migraine, TTH,
probable migraine, probable TTH [32]. Cases of migraine
and probable migraine, and of TTH and probable TTH,
were then combined for prevalence estimation and further
analyses [13]. The remaining cases were unclassified.
Burden enquiry focused on the previous 3 months and,
in those to whom it was relevant, on the day before the
interview. The latter information did not depend upon the
participant’s long-term memory, but the interview was not
structured to diagnose this headache if the participant had
more than one headache type. Symptom burden was
expressed in terms of frequency, intensity and duration.
Questions were also asked about headache-related lost
productivity at work and in the household using the
Headache-Attributed Lost Time (HALT) questionnaire
[33], and WTP.
Analysis and statistics
We recorded typical headache intensity on a verbal rat-
ing scale (“not bad”, “quite bad” and “very bad”), trans-
formed these data into a numerical scale 1-3, and
treated them as continuous data, calculating a mean for
the sample. We recorded headache frequency as con-
tinuous data in days affected per month. We recorded
duration of headache as continuous data in hours. For
both these we calculated means for the sample, and from
them derived the average time spent in the ictal state.
To calculate disability we used disability weights (DWs)
from GBD2010 [34].
All analyses were performed with SAS version 9.2 (SAS
Institute Inc., Cary, NC, USA) or Excel 2007 (Microsoft
Corporation, Redmond, WA, USA). Statistics are mainly
descriptive. When appropriate we calculated P-values as
an aid to interpretation, using Student’s t test and chi-
squared to compare distributions and proportions.
Results
Of 1,134 unrelated household members aged 18-65 years
with whom contact was made, 1,085 (450 male, 635 fe-
male; 198 rural [Southern Province], 887 urban [Lusaka
Province]) consented to be interviewed (refusal rate
4.3%). The male/female ratio (41.5:58.5) diverged from
the national ratio for this age range (very close to 50:50)[25]; the ratio of urban/rural dwelling (82:18) also did
not match the urban/rural distribution (40:60) of the
Zambian population [25]. Statistical adjustments to ob-
served prevalences were therefore necessary for both
gender and habitation [24]. In other respects our sam-
ples were demographically comparable to the Lusaka
and Southern Province general populations [24,25].
The prevalence data have been reported previously
[24]. In summary, 781 participants (72.0%; males 66.2%,
females 76.1%) reported headache unrelated to another
illness in the past year, and 307 (28.3%; males 21.3%,
females 33.1%) reported headache on the day prior to
the interview (headache yesterday). Adjusted for gender
and habitation, the 1-year prevalence of any headache
was 61.6% and the point prevalence (headache yesterday)
was 19.1%. The gender- and habitation-adjusted 1-year
prevalence of migraine was 22.9%, of TTH 22.8%, of
headache on ≥15 days/month 11.5%, of pMOH 7.1%.
Prevalence of pMOH was much higher in urban (14.5%
gender-adjusted) than in rural populations (2.1%).
Individual burden
The individual symptom burden arising from migraine is
shown in Table 1. Reported mean intensity of attacks
was 2.7, equating to severe pain. Headache was reported
on an average of 3.4 days/month [24], with a mean dur-
ation of 36.4 hours. As this was >24 hours, it implied
a mean attack frequency of 2/month, each extending
into 2 days. The consequence would be 10.0% of all
time spent in the ictal state (calculated as 100*[2*36.4*12]/
[365*24]).
Applying the GBD2010 DW of 0.433 for the ictal state
of migraine [34] generated a disability level of 4.3%
(0.433*10.0%). This was the mean estimated disability
attributed to migraine per adult with the disorder in
Zambia.
We did not complete similar estimates for TTH. Head-
ache intensity for TTH was 1.9 (moderate), with a mean
of 2.5 days/month recorded with headache. The GBD2010
DW for the ictal state of TTH was only 0.04 [34], so the
Table 3 Willingness to pay for effective care, against
diagnosis and income





Income per month (USD)
(mean [SD])
240 [218] 206 [190] 158 [160]
Willingness to pay (USD)
(mean [SD])
1.67 [2.85] 1.60 [2.80] 1.54 [2.62]
% WTP of income
(mean [SD])
1.4% [3.0] 1.8% [5.1] 1.8% [3.5]
TTH: tension-type headache; pMOH: probable medication-overuse headache.
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with the disorder would be quite low.
For pMOH, we did not have reliable reported data for
time spent in the ictal state. Most participants claimed
to have headache every day (mean 29.8 days/month),
and by definition it occurs on ≥15 days/month. We took
a more conservative estimate of 75%, and assumed head-
ache was present for only one half of the time because
of the effect of treatment. Thus we calculated mean time
in ictal state as 37.5% of total time. GBD2010 did not
report a DW for MOH, but this disorder was included
in the global consultation for deriving DWs: for the
headache state of MOH, a DW of 0.220 was assigned
[unpublished]. Thus the mean estimated disability attri-
buted to MOH per adult with this disorder would be
8.3% (0.220*37.5%).
We had data for lost productive time to relate to these
estimates, deriving from the HALT questionnaire [33]
(Table 2). On average, people with migraine lost 4.1 days
from work in the preceding 3 months, and much the
same, 4.2 days, from household work. Assuming a 13-
week period had 65 workdays, the former represented a
6.3% loss, compared with the estimated disability level of
4.3%. For household work, the denominator was pre-
sumably 90 days, in which case the loss was 4.7%. The
quartiles make clear that a highly-disabled minority
accounted for a substantial proportion of these losses.
The losses for people with pMOH were somewhat but
not very much greater: from paid work, 4.8 days repre-
sented a 7.4% loss, and from household work 4.5%
represented 5.0% compared with the estimated disability
level of 8.3%. Again, a highly disabled minority accounted
for much of these losses. More than half of people with
TTH lost no productive time at all, and total losses to this
disorder were low.
We also had data on WTP for effective health care for
headache, if it were available, and on income to set this
in context (Table 3). Both questions were answered fully
by 651 participants. Income levels in Zambia were low –
around USD 200 per month on average, with a modestTable 2 Lost productive time in preceding 3 months
according to HALT questionnaire






Migraine 4.1 (6.6) 4.2 (7.4) 1.3 (2.8)
[0; 2; 5; 45] [0, 2, 5, 67] [0; 1; 0; 30]
TTH 1.4 (2.8) 1.1 (3.0) 0.4 (1.2)
[0; 0; 2; 24] [0; 0; 1; 35] [0; 0; 0; 14]
pMOH 4.8 (8.2) 4.5 (7.3) 1.0 (1.8)
[0; 3; 7; 60] [0; 4; 6; 70] [0; 1; 1; 15]
Values are means (SD) [quartile 1; median; quartile 3; upper limit of range].
TTH: tension-type headache; pMOH: probable medication-overuse headache.difference between migraine and TTH (P = 0.07) but
those with pMOH had significantly lower income (2-tailed
Student’s t test vs migraine: P < 0.0001). WTP perhaps
reflected this: means ranged from USD 1.54 to USD 1.67
per month, or, as a percentage of income, from 1.4 to
1.8%. Differences between the diagnoses in absolute WTP
were small and insignificant; in percentage terms, those
with migraine were willing to pay less than all others, but
this appears artefactual. A total of 39 participants claimed
a WTP >5% of their income, 14 (5.6%) diagnosed with mi-
graine (maximally 33%), 15 (5.7%) with TTH (maximally
50%) and 10 (7.3%) with pMOH (maximally 25%).
Population-level burden
Returning to Tables 1 and 2, we made estimates of bur-
den at population level, and on society. Each person with
migraine was 4.3% disabled, while the prevalence of mi-
graine among 18-65 year-olds was 22.9%. Thus there
was a 0.98% (4.3*0.229) disability attributable to mi-
graine among the population of this age. Those with mi-
graine lost 6.3% of workdays, which diluted to 1.4%
among this population, somewhat greater than the esti-
mated underlying disability.
Similar estimates were possible and informative for
pMOH. Individual disability was 8.3%; prevalence 7.1%.
The calculated population-level disability from pMOH
was 0.59%%. Lost workdays were 7.4%, and therefore
0.53% among the population of 18-65 year-olds, only
slightly less than the conservatively estimated underlying
disability.
Headache yesterday
In our earlier manuscript, we noted the high headache
frequency overall of 10.3 days/month, creating, among
the 72.0% with headache, a probability of headache on
any particular day of 0.34 [24]. The predicted 1-day
prevalence of headache was therefore 24.5%, slightly less
but consistent with the 28.3% prevalence of headache
yesterday reported in the sample. We also enquired into
effect of headache yesterday on activities yesterday. Of
307 responders, only 77 (25.1%) reported that they were
able to do everything as normal and a further 45 (14.7%)
Mbewe et al. The Journal of Headache and Pain  (2015) 16:36 Page 5 of 8that they could do more than half of their planned activ-
ities; much larger numbers claimed they could do less
than half (117; 38.1%) or nothing at all (115; 37.5%). We
interpreted these reports conservatively, assuming the
intermediate groups actually managed 80% and 50% re-
spectively, and that the “could-do-nothing” group prob-
ably achieved 25%. On this basis, the average “output”
per person with headache yesterday was 55.9% of expect-
ation. The deficit, spread among the population according
to the gender- and habitation-adjusted prevalence of
19.1%, would be 10.7%, considerably higher than other
population estimates of burden.
Discussion
Just as our first manuscript showed headache to be
highly prevalent in Zambia – no less so than elsewhere
in the world [24] – here we have demonstrated that
there are high levels of burden arising from it. Symptom
burdens affect individuals, particularly those with mi-
graine (22.9% of the adult population) or pMOH (7.1%).
The former spend, on average, an estimated 10.0% of all
their time in the ictal state, which is a very substantial
loss of healthy time, with headache described as severe
(2.7 on a scale 0-3). The consequent disability burden
averaged over time is 4.3%. As might be expected, people
with pMOH carry much more individual disability –
estimated at 8.3%.
These estimates were not exactly reflected in other
measures of burden. People with migraine lost 6.3% of
workdays and 4.7% of household workdays; more than
might be expected in the case of the former, but the
discrepancy might be explained by the very skewed dis-
tribution and a highly-disabled minority. What is at first
surprising is that losses from people with pMOH were
only 7.4% from workdays and 5.0% from household
workdays – higher than for migraine but not greatly so,
whereas the disability estimate was two-fold higher. The
explanation almost certainly lies in the disruptive effect
of episodic migraine, with its short sharp bursts of high
disability, which makes coping difficult. People manage
chronic pain and disability differently, with more em-
phasis on distraction and less on palliation [35]. None-
theless, the greater disability among people with MOH
was, perhaps, reflected in their lower incomes despite
that they were predominantly urban-dwellers.
Perhaps this was why it was migraine, not pMOH, that
generated the highest WTP in absolute terms; indeed,
pMOH generated the lowest. Of course, other factors
come into play with WTP, including affordability, and,
set against income, people with migraine (who had the
highest incomes) demonstrated the lowest relative WTP.
It should be noted that none of these differences was
significant. Respondents with pMOH must already be
spending significant amounts on medication, presumablywith perceived benefit, which would condition their
responses to the enquiry. This does question their low
WTP, unless they saw the enquiry as asking what more
they would pay than they were already. The 39 respon-
dents who would pay >5% of their income (up to 50%,
although they might not pay this in reality) were distrib-
uted reasonably equally between the three diagnostic
groups, slightly more having pMOH.
Part of our purpose was to inform policy, which the
population-level findings do very well. Individual disabil-
ity of 4.3% attributable to migraine extrapolated to a dis-
ability of 0.98% among the entire population aged 18-65
years – effectively the working population. It is import-
ant to recognise this. Individual disability of 8.3% among
those with pMOH extrapolated to 0.59% in the popula-
tion. The total was 1.6%, not including TTH (which
added little). Lost workdays from migraine (6.3%) and
pMOH (7.4%) translated to 1.4% and 0.53% respectively,
which together represented a loss of workforce capacity
of 1.93%, and this huge economic burden would be
reflected in national productivity and gross domestic
product (GDP).
We would like to make comparisons with other
countries, but there is no point in doing so when meth-
odological differences may be the explanation of any
differences [13]. Therefore we limit our observations to
LTB studies, and focus on Georgia and India, both
lower-middle income countries like Zambia [25]. LTB
has completed studies in Nepal, Pakistan and Ethiopia,
but these are not yet fully analysed for publication. In
Georgia, with a much lower 1-year prevalence of 13.7%
[36], people with migraine lost 5.7% of workdays (quite
similar to Zambia) and 4.4% of household workdays
(almost the same) [26]. Losses for people with headache
on ≥15 days/month (prevalence 7.6% [36], two thirds
that of Zambia) were 6.8% from workdays and 5.5% from
household workdays [26], very similar to those from
pMOH in Zambia. In other words, while prevalences
differed between these two countries of both migraine
and headache on ≥15 days/month, recalled lost product-
ivity per person over 3 months was much the same (the
emphasis here being deliberate, as will be seen later).
In Georgia, WTP was several-fold higher in absolute
terms (USD 8 per month for 93% of respondents to the
questions), and sufficient in most cases to pay for effective
care [26]. In Zambia, WTP would contribute little towards
the cost of care. In relative terms, set against GDP (USD
16.13 bn for Georgia versus Zambia’s USD 22.38 bn [25]),
the disparity was even greater. As in Zambia, WTP in
Georgia did not correlate with headache type or fre-
quency, or with lost productive time, which means the ex-
planation for the different levels of WTP is probably
cultural. In Georgia, there is no expectation of free health
care, so the concept of paying for care is not unusual.
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25.6% [unpublished], slightly higher than that in Zambia,
but with nowhere near the level of headache on
≥15 days/month, we have comparative lost workforce
capacity data: for all headache, 1.1% [37]. In Zambia
more than this loss is suffered from migraine alone, with
pMOH adding half as much. The estimate from India is,
as elsewhere, based on participants’ recall of the preced-
ing 3 months, but it was very closely corroborated by
those reporting headache and consequential productivity
losses on the day before their interview. Which brings us
to an obvious discrepancy in the headache yesterday data
from Zambia.
Enquiry into headache yesterday obviates the problem
of faulty recall – highly likely over periods of 3 months
[13]. In fact, based on reported frequency over the pre-
ceding 3 months, the predicted 1-day prevalence of
headache was 24.5%, which reassuringly matched the
28.3% reported prevalence of headache yesterday (the
difference being the numerical part of the recall error).
But when it came to effect of headache on activities yes-
terday, even with conservative interpretation, average
“output” per person with headache yesterday was 55.9%
of what had been intended. The deficit, spread among
the population, would be 10.7%, considerably higher
than other population estimates, and actually unfeasible
as an estimate of headache-attributed population disabil-
ity assumed to be present every day. This phenomenon
has not been encountered in the few surveys of head-
ache yesterday so far conducted in other countries
[37-39], and any explanation is speculative. One is that,
thinking of yesterday, attention focused on and gave
undue weight to many small things left undone. Another
is that, unexpectedly having the undivided attention of a
health-care worker on the doorstep the day after a head-
ache episode, a participant did not wish to downplay its
effect in any way. These are not unlikely explanations,
and we must accept that an unknown degree of exagger-
ation inflated these accounts of productivity loss yesterday.
The much lower estimates based on recall over the pre-
ceding three months are similar to those from Georgia,
also based on recall. The truth in Zambia lies somewhere
between the two estimates of population disability and
productivity loss.
It is a study limitation that we cannot be precise about
this. In our earlier paper, we also recorded our inability
to complete the diagnostic validation exercise satisfactorily
owing to country-based factors beyond our control [24],
but the essential messages here, relating to headache and
medication overuse, are not significantly affected by this
limitation. The study had several strengths, also noted
previously [24]. We employed population-based sampling,
included diverse regions with a sample size of >1,000, and
used ICHD-II diagnostic criteria [32]. The methodologywas established [13], having been tested in numerous
other countries.
Conclusions: what is to be done?
Headache disorders are not only common in Zambia but
also highly burdensome. However, burden does not sit
quite as might be expected: measures of disability and
lost productivity show only loose relationships with head-
ache type and frequency.
At population level, Zambia effectively loses 1.93% of
its GDP to headache – more than in Georgia [26] and
almost double the loss in India [37]. Zambia also loses
more of its GDP to headache than Russia (1.75% [40])
and China (1.9% [41]), other countries in which LTB has
made estimates by the same methods.
Underlying these losses are the high prevalences of
headache disorders, especially pMOH. These are treat-
able disorders [8]. Much could – and should – be done
to alleviate them, partly with the expectation of substantial
cost-saving [7] but also because people with headache lose
much of their quality of life. Structured headache services
with their basis in primary care are the most efficient, ef-
fective, affordable and equitable solution [7]; the model
proposed for Europe [42] is highly adaptable, and could be
reworked to match the health-care infrastructure of
Zambia. These matters require urgent political attention.
Inaction is not an option: medication overuse, and
MOH, are predictable consequences of lack of health
care for migraine and TTH (especially when these are
themselves prevalent), lack of public health education,
and easy access to non-prescription analgesics (hence
the urban-rural divide for pMOH: 14.5% vs 2.1%). In
other words, a remediable problem will instead become
worse.
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